The impact of adherence counseling incorporating a point of care urine tenofovir assay on virologic suppression among individuals failing tenofovir-lamivudine-dolutegravir: A pre-post intervention study

The urine tenofovir assay when incorporated into adherence counseling has potential to be a cost-effective intervention among participants failing tenofovir-based regimens, increasing VS to 97% in those failing Tenofovir-Lamivudine-Dolutegravir. Encouraging results of this pre-post intervention will be rigorously tested in a randomized trial.

Authors

Institutions

Publication Details

Journal
International Journal of Infectious Diseases
Published
2024-12-07
DOI
https://doi.org/10.1016/j.ijid.2024.107328
Citations
9
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
3.50

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The impact of adherence counseling incorporating a point of care urine tenofovir assay on virologic suppression among individuals failing tenofovir-lamivudine-dolutegravir: A pre-post intervention study

Matthew A. Spinelli, Jacques Wa Nsenda Kamangu, Monica Gandhi, Assegid Mengistu et al.
9 citations
International Journal of Infectious Diseases
HIV/AIDS Research and Interventions
3.50
article

The impact of adherence counseling incorporating a point of care urine tenofovir assay on virologic suppression among individuals failing tenofovir-lamivudine-dolutegravir: A pre-post intervention study

Matthew A. Spinelli, Jacques Wa Nsenda Kamangu, Monica Gandhi, Assegid Mengistu, Leonard Bikinesi, Suzanne M. McCluskey, Pearl Kalimugogo, Susie Welty, Iyaloo Konstantinus, Gram Mutandi, Steven Y. Hong, Willi McFarland, Guohong Wang, Ntombizodwa Makurira Nyoni, Fekir Negussie, R. Suzanne Beard, D P Mouton, Professor Jessica Haberer
article en
9 citations

Abstract

The urine tenofovir assay when incorporated into adherence counseling has potential to be a cost-effective intervention among participants failing tenofovir-based regimens, increasing VS to 97% in those failing Tenofovir-Lamivudine-Dolutegravir. Encouraging results of this pre-post intervention will be rigorously tested in a randomized trial.

International Journal of Infectious DiseasesVol. 151
Centers for Disease Control and Prevention (US), Harvard University (US), University of Namibia (NA), Abbott (United Kingdom) (GB), Massachusetts General Hospital (US), Centers for Disease Control and Prevention (UG), Global Solutions for Infectious Diseases (US), Namibia Institute of Pathology (NA), Ministry of Health and Social Services (NA)
U.S. President’s Emergency Plan for AIDS Relief, National Institutes of Health, Centers for Disease Control and Prevention, University of California, San Francisco, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases
Openalex Percentile: Top 6%
HIV/AIDS Research and Interventions
3.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.